Shop Research About Compliance Affiliate Free Consultation

Cagrilintide

Long-Acting Amylin Analog

★★★★★4.6 out of 5(24 reviews)

Amylin receptor agonist. Studied alongside GLP-1 compounds in metabolic models.

✓ HPLC Verified ✓ 99%+ Purity ✓ COA Available ✓ Ships in 24hr ✓ US-Based ✓ Direct Support
📋 Certificate of Analysis Request COA via Telegram
Cagrilintide research peptide vial
Select Size
$265
10-vial kit
+ $40 shipping · Free over $500 · Ships worldwide
✓ Added to cart View Cart →
Research Data

What Is Cagrilintide?

Cagrilintide is a long-acting amylin analog developed by Novo Nordisk. Amylin is a pancreatic peptide that reduces appetite and slows gastric emptying through central nervous system pathways distinct from GLP-1. Combined with semaglutide (CagriSema), it demonstrated up to 22.7% weight reduction in phase 2 trials.

Research Context

  • Amylin receptor agonism and hypothalamic appetite signaling
  • Combination with GLP-1 agonists for additive appetite suppression (CagriSema trials)
  • Gastric emptying modulation and postprandial glucose control
  • Dual-pathway weight management research vs single-agent approaches

Storage & Reconstitution

Store lyophilized at -20°C. Reconstituted: refrigerate 2–8°C, use within 4–6 weeks.

All products sold for research purposes only. Not for human or animal consumption. Must be 18+ to purchase. By placing an order you confirm compliance with all applicable local laws and regulations.